Wednesday, July 26, 2017
 
 
Company News: Page (1) of 1 - 03/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Innophos 2017 Investor Day Rescheduled For April 5th
Company to Unveil New Strategic Growth Roadmap and Long-term Financial TargetsEvent to be Webcast Live on April 5 at 8:30 a.m. ET
(March 17, 2017)

CRANBURY, N.J., March 17, 2017 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: IPHS), a leading international producer of specialty ingredient solutions, today announced that it will hold and webcast its Investor Day for investors and analysts on April 5, 2017 from 8:30 a.m. to approximately 12:00 p.m. ET. The Company had previously postponed the event due to severe winter weather in the New York City area.  At the event, Innophos' management team will unveil the Company's strategic roadmap and long term growth prospects.

The live audio webcast and presentation slides will be accessible in the "Investors" section of Innophos' website.  The event will be archived on the Company's website for approximately one year. 

For those investors and analysts interested in attending the event, please RSVP via email to [email protected].  The event will be limited to investors and analysts only. All participants must be registered in advance to attend, as space is limited.


About Innophos
Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphate, mineral and botanical based ingredients to help our customers offer products that are tasty, healthy, nutritious and economical. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. For more information, please visit www.innophos.com. 'IPHS-G'

Investor Contact                                    

Media Contact          


Mark Feuerbach                                          

Ryan Flaim                 


Innophos                                                      

Sharon Merrill Associates 


609-366-1204                                               

617-542-5300    


[email protected]                 

[email protected] 


To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/innophos-2017-investor-day-rescheduled-for-april-5th-300425516.html

SOURCE Innophos Holdings, Inc.

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Science, Email,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Global Neuropsychiatric Disorders And Treatment Market Is Expected To Grow At A CAGR Of 6.2% During Forecast 2023
  • Urology Devices Global Market - Forecast to 2023
  • ChiRhoStim® (Human Secretin for Injection) FDA approved labeling update and 5-year shelf life approval
  • Wound Closure and Advanced Wound Care Global Market Forecast To 2023
  • Longeveron to Sponsor Industry Symposium on Regenerative Medicine at 2017 IAGG World Congress

    Cancer
  • Santen and TRACON Announce Initiation of a Phase 2a Study of DE-122 for the Treatment of Wet Age-Related Macular Degeneration
  • Asia-Pacific Immunodiagnostics Analyzers and Reagents Market 2021: A 17-Country Analysis--Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review
  • Varian to Showcase Latest Radiotherapy and Radiosurgery Technologies and Software at AAPM 2017
  • American Brain Tumor Association's Annual Patient and Family Conference to Address Physical and Cognitive Symptoms and Side Effects
  • St. Jude Children's Research Hospital®, ALSAC Announce Chairs of Boards of Directors and Governors
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines